Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
Clinical trial NCT06137053 · UNKNOWN
Trial details
- NCT number
- NCT06137053
- Sponsor
- Yanfeng Hou
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-01
- Primary completion
- 2025-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.